Condition: Crohn Disease (CD) · Sponsor: Alimentiv Inc.
This is a multicentre, prospective, randomised, controlled, open-label study to assess the efficacy, safety, and cost-effectiveness of epigenome-guided treatment selection compared to usual standard-of-care (SOC) treatment selection in patients initiating biologic therapy for the treatment of their active Crohn's Disease (CD).
This description comes directly from the study's public registry record.
Susan Archer · susan.archer@alimentiv.com
Lauren Schleicher · lauren.schleicher@alimentiv.com
Always discuss trial participation with your own doctor first.
| GZA Antwerpen | Antwerp, Belgium | Not Yet Recruiting |
| Imeldahospital | Bonheiden, Belgium | Recruiting |
| AZ Klina | Brasschaat, Belgium | Recruiting |
| H.U.B. - Hôpital Erasme | Brussels, Belgium | Recruiting |
| Universitair Ziekenhuis Antwerpen (UZA) | Edegem, Belgium | Recruiting |
| AZ Maria Middelares | Ghent, Belgium | Recruiting |
| AZ Sint Lucas | Ghent, Belgium | Recruiting |
| UZ Ghent | Ghent, Belgium | Recruiting |
| UZ Leuven Gasthuisberg | Leuven, Belgium | Recruiting |
| UZ Leuven | Leuven, Belgium | Recruiting |
| Centre Hospitalier Universitaire (CHU) de Liege | Liège, Belgium | Recruiting |
| Groupe sante CHC/Clique du MontLegia | Liège, Belgium | Recruiting |
+ 27 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07363044